Dr. Amy A. Pruitt, MD

Dr. Pruitt practices at Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania.

Dr. Pruitt's NPI, 1285673798, was assigned on June 6, 2006. Dr. Pruitt graduated from Harvard Medical School in 1974. Dr. Pruitt holds Pennsylvania license MD045167L.

Dr. Pruitt's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-3606.

Dr. Pruitt's primary practice is Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania. Dr. Pruitt is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Pruitt to 5 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pruitt practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Pruitt's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Pruitt is licensed in Pennsylvania.

CMS data shows 347 Medicare services from Dr. Pruitt across 8 procedure codes in 2024, for 239 Medicare patients. Medicare paid $28,084 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 239 Medicare patients who saw Dr. Pruitt in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 19% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pruitt's median patient age at 60, with 66% women.

In 2024, Dr. Pruitt wrote 1,337 Medicare Part D claims for 150 patients. 82% of them were for generic drugs. CMS names the drug for 1,077 of them, across 28 drugs with 11 or more claims each, at $1,588,978 in total drug cost. In 2023, CMS named 1,228 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Pruitt for performance year 2024, reported as part of a group. Dr. Pruitt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pruitt as offering telehealth.

Dmand AI links 12 papers to Dr. Pruitt, published from 2012 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Lyme Disease and Rheumatology. Dr. Pruitt has published most often in Neurohospitalist. Dr. Pruitt's most frequent co-authors are Kiran K. Belani, MBBS, MD, Francis J. Dimario, MD and John J. Halperin, MD.

CMS Open Payments shows 2 general payments to Dr. Pruitt from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $131.

Dr. Pruitt graduated from Harvard Medical School in 1974.